Global Cell Therapy Market Size Worth USD 27.95 Billion By 2030 at a CAGR of 12.1 percent - Benzinga
| 065660 Stock | KRW 17,090 420.00 2.52% |
About 55% of AnterogenCoLtd's investors are presently thinking to get in. The analysis of current outlook of investing in AnterogenCoLtd suggests that some traders are interested regarding AnterogenCoLtd's prospects. The current market sentiment, together with AnterogenCoLtd's historical and current headlines, can help investors time the market. In addition, many technical investors use AnterogenCoLtd stock news signals to limit their universe of possible portfolio assets.
AnterogenCoLtd |
Global Cell Therapy Market Size Worth USD 27.95 Billion By 2030 at a CAGR of 12.1 Benzinga
Read at news.google.com
 |
AnterogenCoLtd Fundamental Analysis
We analyze AnterogenCoLtd's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AnterogenCoLtd using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AnterogenCoLtd based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Outstanding
Shares Outstanding Comparative Analysis
Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
AnterogenCoLtd Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with AnterogenCoLtd stock to make a market-neutral strategy. Peer analysis of AnterogenCoLtd could also be used in its relative valuation, which is a method of valuing AnterogenCoLtd by comparing valuation metrics with similar companies.
Peers
AnterogenCoLtd Related Equities
| DT3 | DOLLAR TREE | 1.38 |
|
Complementary Tools for AnterogenCoLtd Stock analysis
When running AnterogenCoLtd's price analysis, check to measure AnterogenCoLtd's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AnterogenCoLtd is operating at the current time. Most of AnterogenCoLtd's value examination focuses on studying past and present price action to predict the probability of AnterogenCoLtd's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AnterogenCoLtd's price. Additionally, you may evaluate how the addition of AnterogenCoLtd to your portfolios can decrease your overall portfolio volatility.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |